News

Pioneering research conducted by University of Virginia in collaboration with Manchester UK based APIS Assay Technologies Ltd has discovered Hormone-Upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase (HULLK) is detectable in non-invasive prostate cancer patient samples. The breakthrough data provides...

Ypsomed advances its patch injector into a comprehensive solution by entering into a collaboration with SCHOTT, one of the leading suppliers of pharmaceutical primary packaging, and Lonza, a leading global partner of the pharmaceutical and biotechnology industry for the...

Pharmaceutical supply chains are about to face their biggest security challenge for a generation as the world prepares for life-changing deliveries of Covid vaccines, says the Transported Asset Protection Association (TAPA). An estimated 7-19 billion doses of the vaccine will...

Vibalogics, a global contract development and manufacturing organization (CDMO), has today announced that it has initiated Phase I of its planned $150m investment in a late-phase clinical and commercial virotherapy manufacturing facility near Boston, Massachusetts. The three-year investment plan includes...

Contract development and manufacturing organization (CDMO), Stelis BioSource, a division of Stelis Biopharma, has started the next phase of its continued investment program after having already invested more than $100 million into its facilities in Bangalore, India. The latest phase...

One could witness slow revenue growth of Dose Contract Manufacturing Organizations in 2019. Expectations were high on its revival in 2020, but unfortunately, things haven’t been the way they should be. On the contrary, the revenues have depleted further...

A Covid-19 vaccine co-developed by pharmaceutical company AstraZeneca and the University of Oxford is seen as one of the most promising of all the experimental candidates currently being tested on humans. Dubbed ‘Covishield‘, the vaccine is currently in the...